Newsletter Tool

Today's Rundown

Intellia now has the data for No. 1 unanswered gene editing question: Does it last?
Handheld ultrasound developer Butterfly Network stretches wings to 35% annual sales growth
Editor's Corner: Fierce Biotech gets a fierce makeover
Teladoc inks Amazon partnership for voice-activated virtual visits on Echo devices
UPDATED: Biotech leaders call on industry to cut ties with Russia amid Ukraine invasion
CDC unveils new masking guidance based on community-level hospital capacity, severe infection risk
FDA stresses the importance of regular checkups for aortic aneurysm implants
Advantage Pfizer: GSK stops phase 3 trials of maternal RSV vaccine after seeing safety signal
Dentsply Sirona brings digital dentistry to Google Cloud, launches 3D printing system
Providers relieved CMS chose to overhaul Direct Contracting Model instead of canceling it
Masimo’s brain-monitoring headset nabs FDA nod for use in kids
Gemini CEO out the door as 80% of staff laid off, strategic review gets underway
Chartis Group: Medicare Advantage enrollment grew by 2.3M for 2022 as for-profit plans see boost
Surgical stapler maker Standard Bariatrics sews up $35M

Featured Story

Intellia now has the data for No. 1 unanswered gene editing question: Does it last?

By Annalee Armstrong

Intellia proved last year that gene editing can work in humans. But a lingering question was, for how long? Now, the biotech has the data to begin to answer that question.

Handheld ultrasound developer Butterfly Network stretches wings to 35% annual sales growth

By Conor Hale

With point-of-care ultrasound probes and subscription plans, the company raked in $62.6 million in 2021 compared to 2020's $46.3 million.

Editor's Corner: Fierce Biotech gets a fierce makeover

By Annalee Armstrong

Fierce Biotech is rolling out some big changes to help you get the news, analysis and insights you need in an easier-to-read format on our webpages.

Teladoc inks Amazon partnership for voice-activated virtual visits on Echo devices

By Rebecca Torrence

Amazon and Teladoc are teaming up to offer on-demand general medical care through Amazon's Alexa-enabled devices, available to U.S. customers 24/7.

UPDATED: Biotech leaders call on industry to cut ties with Russia amid Ukraine invasion

By Kyle LaHucik,Annalee Armstrong,Max Bayer,Eric Sagonowsky,Kevin Dunleavy

CEOs at dozens of biotechs and investors from the industry's leading venture firms urged their global business counterparts to "disengage from Russian industry" over the weekend.

CDC unveils new masking guidance based on community-level hospital capacity, severe infection risk

By Dave Muoio

The revamped approach is designed to predict whether a community's hospitals will be overrun with new COVID-19 cases within the next three to six weeks, CDC Director Rochelle Walensky, M.D., said Friday. Under the new model, CDC is no longer recommending universal public mask wearing indoors or in schools for the majority of U.S. counties.

FDA stresses the importance of regular checkups for aortic aneurysm implants

By Andrea Park

According to the FDA’s letter, complications from endovascular aneurysm repair devices could be detected much earlier—potentially reducing long-term mortality rates—if patients and physicians stick to a regular checkup schedule.

Advantage Pfizer: GSK stops phase 3 trials of maternal RSV vaccine after seeing safety signal

By Nick Paul Taylor

Hopes of a quick fix for GlaxoSmithKline’s respiratory syncytial virus (RSV) vaccine woes are fading fast. Having voluntarily paused three maternal RSV vaccine clinical trials 10 days ago, GSK has now stopped enrollment and vaccination in the studies as it works to better understand the safety data.

PM Tracker

Featured Story

Intellia now has the data for No. 1 unanswered gene editing question: Does it last?

Top Stories

Handheld ultrasound developer Butterfly Network stretches wings to 35% annual sales growth

Editor's Corner: Fierce Biotech gets a fierce makeover

Teladoc inks Amazon partnership for voice-activated virtual visits on Echo devices

UPDATED: Biotech leaders call on industry to cut ties with Russia amid Ukraine invasion

CDC unveils new masking guidance based on community-level hospital capacity, severe infection risk

FDA stresses the importance of regular checkups for aortic aneurysm implants

Advantage Pfizer: GSK stops phase 3 trials of maternal RSV vaccine after seeing safety signal

Dentsply Sirona brings digital dentistry to Google Cloud, launches 3D printing system

Providers relieved CMS chose to overhaul Direct Contracting Model instead of canceling it

Masimo’s brain-monitoring headset nabs FDA nod for use in kids

Gemini CEO out the door as 80% of staff laid off, strategic review gets underway

Chartis Group: Medicare Advantage enrollment grew by 2.3M for 2022 as for-profit plans see boost

Surgical stapler maker Standard Bariatrics sews up $35M